Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Acuity closes $15mm second round

Executive Summary

Acuity Pharmaceuticals, a developer of small interfering RNA (siRNA) therapeutics for eye diseases, raised $15mm in a Series B private financing led by Psilos Group Managers. Also participating were additional new investors including Johnson and Johnson Development Corp. (JJDC), Och-Ziff Capital Management Group, Diamond Capital, Trans-Science, BioAdvance, and Ben Franklin Technology Partners.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies